Is Nurix Therapeutics, Inc. (NRIX) a Buy, Sell, or Hold?
NASDAQ : NRIX
Nurix Therapeutics, Inc. — Analyst Ratings
$23.21 USD
-$0.37 (-1.57%)
- Volume
- 751.72K
- Average Volume
- 2.03M
- Market Capitalization
- $2.41B
- P/E Ratio
- -6.73
- Dividend Yield
- 0.00%
- Price Target
- $34.00
- Year High
- $25.09
- Year Low
- $8.20
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $6.34
Analyst Consensus Summary
Consensus Rating
Strong Sell
19 Analysts
Rating Score
1/5
Recommendation Strength
Upside/Downside
-31.7%
vs Current Price
Price Target
$34.00
Average TargetPrice Target Range
Lowest Target
$28.00
-17.1% DOWNSIDE
Average Target
$34.00
Median Estimate
Highest Target
$45.00
-48.4% DOWNSIDEAnalyst Breakdown
Overall Consensus: Buy | Total Analysts: 19
| Strong Buy | Buy | Hold | Sell | Strong Sell |
|---|---|---|---|---|
| 0 | 19 | 0 | 0 | 0 |
Analyst Ratings (Detailed)
| Analyst Company | Analyst Name | Price Target | Price When Posted | Date | Upside/Downside |
|---|---|---|---|---|---|
| Mizuho Securities | Joseph Catanzaro | $34 | $23.06 | 2026-07-13 06:43 AM | 47.4% |
| Truist Financial | Gregory Renza | $34 | $23.0472 | 2026-07-10 08:41 AM | 47.5% |
| UBS | David Dai | $23 | $15.07 | 2026-06-09 09:30 AM | 52.6% |
| BTIG | Jeet Mukherjee | $32 | $15.64 | 2026-06-09 07:19 AM | 104.6% |